PMCB
Closed
Pharmacyte Biotech Inc
1.14
+0.05 (+4.59%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.09
Day's Range: 1.09 - 1.15
Send
sign up or login to leave a comment!
When Written:
2.93
PharmaCyte Biotech Inc is a biotechnology company that focuses on developing and commercializing cell-based therapies for cancer and diabetes. The company's proprietary technology, called Cell-in-a-Box, is a platform that encapsulates living cells in a protective capsule, allowing for targeted delivery of therapeutic agents to specific areas of the body.
PharmaCyte Biotech's lead product candidate is a treatment for advanced pancreatic cancer using the Cell-in-a-Box technology. The company is also developing treatments for other types of cancer, as well as diabetes.
Founded in 1996, PharmaCyte Biotech is headquartered in Silver Spring, Maryland, and has research and development facilities in Australia. The company is publicly traded on the OTCQB market under the ticker symbol PMCB.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
PharmaCyte Biotech's lead product candidate is a treatment for advanced pancreatic cancer using the Cell-in-a-Box technology. The company is also developing treatments for other types of cancer, as well as diabetes.
Founded in 1996, PharmaCyte Biotech is headquartered in Silver Spring, Maryland, and has research and development facilities in Australia. The company is publicly traded on the OTCQB market under the ticker symbol PMCB.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








